Azure Life Sciences: Subsidiary Obtains New Animal Drug Registration Certificate

On September 17, Weilan Biotechnology announced that its wholly-owned subsidiary, Qingdao Kangdien Animal Pharmaceutical Co., Ltd., jointly applied for the "Fluralaner Drops" and "Fluralaner Drops" with other units, and obtained the "New Veterinary Drug Registration Certificate" issued by the Ministry of Agriculture and Rural Affairs. Fluralaner drops are primarily used to treat flea and tick infestations on the skin of dogs and cats, with the characteristics of fast-acting and long-lasting protection. The acquisition of this new veterinary drug certificate is expected to bring new performance growth points to the company's business.